Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) impacts ca. 30% of the global population and is very heterogeneous, making it a challenge to develop therapeutics. The heterogeneity arises from genetics, co-morbidities, the microbiome, and lifestyle. To help address this cha...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Julio Aleman, Lawrence Vernetti, Mark E. Schurdak, Richard DeBiasio, Greg LaRocca, Vijay K. Yechoor, D. Lansing. Taylor, Andrew M. Stern, Mark T. Miedel
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2026-04-01
Rangatū:	BMC Biotechnology
Ngā marau:	Metabolic dysfunction-associated steatotic liver disease (MASLD) Human microphysiology systems (MPS) Metabolic disease mechanism Hepatic steatosis Hepatic insulin resistance Hyperglycemia
Urunga tuihono:	https://doi.org/10.1186/s12896-026-01158-6
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!